Cargando…

1438. Latent tuberculosis infection (LTBI) in hematopoietic stem cell transplantation (HSCT) recipients: a retrospective Italian cohort study in Tor Vergata University Hospital, Rome.

BACKGROUND: Patients undergoing haematopoietic stem cell transplantation (HSCT) have severe and prolonged immunodeficiency and the incidence of tuberculosis (TB) disease in those patients is 10 to 40 times higher than the general population METHODS: This retrospective study performed at Tor Vergata...

Descripción completa

Detalles Bibliográficos
Autores principales:	Compagno, Mirko, Navarra, Assunta, Campogiani, Laura, Coppola, Luigi, Benedetta, Rossi, Marco, Iannetta, Goletti, Delia, Sarmati, Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752906/ http://dx.doi.org/10.1093/ofid/ofac492.1267

Ejemplares similares

Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome
por: Compagno, Mirko, et al.
Publicado: (2022)

The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy
por: Di Lorenzo, Andrea, et al.
Publicado: (2023)

Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience
por: Campogiani, Laura, et al.
Publicado: (2023)

Response of a Radiology Department to the SARS-CoV-2 Pandemic: The Experience of the Hospital “Policlinico Tor Vergata” in Rome
por: Malizia, Andrea, et al.
Publicado: (2021)

766. Migration Flows and Increase of Extrapulmonary Tuberculosis in a Low Prevalence Setting: A Retrospective Analysis in Two Italian Centers
por: Compagno, Mirko, et al.
Publicado: (2018)

Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production
por: Alessio, Grazia, et al.
Publicado: (2022)

Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome
por: Postorino, Massimiliano, et al.
Publicado: (2020)

Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study
por: Campogiani, Laura, et al.
Publicado: (2023)

Der transsilvanische volksaufstand, 1437-1438
por: Pascu, Tefan
Publicado: (1964)

Increased Mild Vaccine-Related Side Effects and Higher Specific Antibody Titers in Health Care Workers with Previous SARS-CoV-2 Infection after the mRNA BNT162b2 Vaccine
por: Ferrari, Ludovica, et al.
Publicado: (2022)

Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland
por: von Both, Ulrich, et al.
Publicado: (2021)

Prevalence of Latent Tuberculosis Infection (LTBI) in Mexican Patients With Rheumatoid Arthritis (RA)
por: Zavala del Ángel, Abel Eduardo, et al.
Publicado: (2023)

Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea – A problem of low coverage rate with current LTBI strategy
por: Kim, Hyung Woo, et al.
Publicado: (2023)

Viruses of Respiratory Tract: an Observational Retrospective Study on Hospitalized Patients in Rome, Italy
por: Ciotti, Marco, et al.
Publicado: (2020)

Risk factors for latent tuberculosis infection (LTBI) in health profession’s students of the University of Parma
por: Bonini, Silvia, et al.
Publicado: (2017)

International Seminars on Planetary Emergencies "Ettore Majorana" : Festschrift Tor Vergata 10th Anniversary
por: Pichi-Sermolli, Cristina
Publicado: (1999)

Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards
por: Campogiani, Laura, et al.
Publicado: (2019)

Comparison of IFN-γ Levels in Children with Tuberculosis Disease (TB) and Latent Tuberculosis Infection (LTBI)
por: Boskovska, Katerina, et al.
Publicado: (2018)

In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production
por: Imeneo, Alessandra, et al.
Publicado: (2022)

753. Screening for Latent Mycobacterium tuberculosis Infection (LTBI): A Clinical Conundrum of Public Health Concern
por: Bricker, Lauren, et al.
Publicado: (2018)

The Prevalence and Demographic Risk Factors for Latent Tuberculosis Infection (LTBI) Among Healthcare Workers in Semarang, Indonesia
por: Erawati, Meira, et al.
Publicado: (2020)

Draft Genome Sequence of Salirhabdus euzebyi Strain Q1438
por: Zgheib, Rita, et al.
Publicado: (2020)

Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization
por: Iannetta, Marco, et al.
Publicado: (2022)

Correction: Malizia et al. Response of a Radiology Department to the SARS-CoV-2 Pandemic: The Experience of the Hospital “Policlinico Tor Vergata” in Rome. Int. J. Environ. Res. Public Health 2021, 18, 5255
por: Malizia, Andrea, et al.
Publicado: (2022)

938 Identification of High Risk Healthcare Workers with Latent Tuberculosis Infection (LTBI) in an Inner City Healthcare System
por: Dhar, Sorabh, et al.
Publicado: (2014)

Prevalence and Risk Factors of Latent Tuberculosis Infection (LTBI) in Patients with Type 2 Diabetes Mellitus (T2DM)
por: Ping, Phan Ai, et al.
Publicado: (2021)

The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)
por: Zellweger, Jean-Pierre, et al.
Publicado: (2020)

T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers
por: Iannetta, Marco, et al.
Publicado: (2021)

280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination
por: Cavasio, Rosario Alessandro, et al.
Publicado: (2022)

2169. A 4-Year Analysis of Antimicrobial Susceptibility to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: How Drug Availability Affects Resistance Rate
por: Imeneo, Alessandra, et al.
Publicado: (2023)

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

1869. Knowledge about and Perceptions of Latent Tuberculosis Infection (LTBI) among Physicians and Advanced Practice Providers at Tufts Medical Center
por: Boomsma, Cassidy, et al.
Publicado: (2023)

1438. Hand Hygiene Compliance and Monitoring among Healthcare Workers at an Urban Hospital in the Caribbean.
por: Nwaogu, Ezinne U M
Publicado: (2023)

Multi-Level Barriers to LTBI Treatment: A Research Note
por: Hill, Linda, et al.
Publicado: (2008)

1692 Do Resident Physicians Agree with LTBI Treatment Guidelines?
por: Janakiraman, Arun, et al.
Publicado: (2014)

Human Arboviral Infections in Italy: Past, Current, and Future Challenges
por: Rossi, Benedetta, et al.
Publicado: (2023)

1139. Oral Antivirals Against SARS-CoV-2: a New Valid Strategy Against COVID-19
por: Braccialarghe, Neva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j7lekubi8kd93q6t6j9afa9lpo